Studies have demonstrated the dysregulation of NEAT1 expression during the progression of cancer, where its expression is considerably linked to tumor size, distant metastasis, TNM stage, drug resistance, and patient survival [123,124,125]. The gene discussed is NEAT1; the disease is cancer.